Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 

Slides:



Advertisements
Similar presentations
Pascal Rischmann  European Urology Supplements 
Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
A. Wesley Burks, MD, Susan Laubach, MD, Stacie M. Jones, MD 
Volume 58, Issue 1, Pages (July 2010)
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
Volume 74, Issue 1, Pages (July 2018)
Volume 51, Issue 1, Pages (January 2007)
Volume 52, Issue 3, Pages (September 2007)
Advances in Specific Immunotherapy for Prostate Cancer
Let the Games Begin (with EAU Approval)
Volume 68, Issue 1, Pages (July 2015)
Prostate Cancer Epidemic in Sight?
Volume 50, Issue 5, Pages (November 2006)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 52, Issue 1, Pages (July 2007)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
Volume 71, Issue 1, Pages 1-3 (January 2017)
Volume 52, Issue 5, Pages (November 2007)
Volume 68, Issue 1, Pages 5-7 (July 2015)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Toll-like Receptors Keep Antigen Sorting on the Right Track
Prostate Cancer Detection: A View of the Future
Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma
Volume 56, Issue 2, Pages (August 2009)
Volume 68, Issue 1, Pages (July 2015)
Volume 70, Issue 1, Pages (July 2016)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 50, Issue 3, Pages (September 2006)
Volume 61, Issue 6, Pages (June 2012)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Volume 51, Issue 5, Pages (May 2007)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Volume 47, Issue 1, Pages (January 2005)
Volume 52, Issue 1, Pages (July 2007)
The Economic Costs of Overactive Bladder in Germany
Volume 54, Issue 6, Pages (December 2008)
Volume 50, Issue 5, Pages (November 2006)
Volume 134, Issue 5, Pages (May 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Dendritic Cells Break Bonds to Tolerize
Testicular Cancer Variations in Time and Space in Europe
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
Dendritic cells: regulators of hepatic immunity or tolerance?
Sergio Bracarda  European Urology Supplements 
European Urology is “Your” Journal
TIGIT and CD226: Tipping the Balance between Costimulatory and Coinhibitory Molecules to Augment the Cancer Immunotherapy Toolkit  Kristen E. Pauken,
Franco Locatelli, Damiano Rondelli, G.Roberto Burgio 
Volume 143, Issue 1, Pages (July 2012)
Dietary Fat Inflames CD4+ T Cell Memory in Obesity
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Joaquim Bellmunt  European Urology Supplements 
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Jan Roigas  European Urology Supplements 
T cells and T-cell receptors in acute renal failure
Volume 54, Issue 1, Pages (July 2008)
Immune pathomechanism of drug hypersensitivity reactions
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Therapeutic Dendritic Cell Vaccination of Patients with Renal Cell Carcinoma  Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology  Volume 50, Issue 1, Pages 34-43 (July 2006) DOI: 10.1016/j.eururo.2006.03.061 Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 1 Activation of naïve CD4 or CD8 T cells requires two independent signals. Binding of T-cell receptor (TCR) to the antigen-HLA complex on the dendritic cell (DC) delivers a signal (signal 1) that can induce activation and expansion of T cells when the costimulatory signal (signal 2) is given by binding of CD28 to B7 molecules. European Urology 2006 50, 34-43DOI: (10.1016/j.eururo.2006.03.061) Copyright © 2006 European Association of Urology Terms and Conditions